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S1. Sampling and chemical analyses
Sampling. Maternal blood-from a cubital vein of the mother during week 32 of the pregnancy (last antenatal examination, non-fasting)-was collected in an evacuated Vacutainer tube (10 mL) without anticoagulant (Becton-Dickinson, Rutherford, New Jersey, USA). Serum was harvested after centrifugation of the coagulated sample. Cord blood was collected immediately after the cord had been clamped by using 10-mL Abbott syringes with Teflon-lined pistons (Abbott Ireland Ltd, Sligo, Ireland). Both whole blood and serum were obtained. All maternal and cord serum samples were transferred into Minisorb tubes (Nunc, Roskilde, Denmark) for storage.
After cord blood collection for whole blood and serum specimens, a minimum of 10 cm of cord tissue was taken close to the umbilicus of the infant and placed into a Minisorb tube. Subsequently, the placenta was secured, and multiple cube-like pieces were cut from both peripheral and central lobes. Visible calcium deposits and white infarct areas were avoided. The first approximately 4 mm from the maternal side-i.e., the basal deciduawas removed from each cube. Any marginal tissue, which is entirely of maternal origin, was removed as well, as was the chorionic plate; hence, the specimen collected consisted of placental/trophoblastic tissue of fetal origin. Maternal blood is easier to remove than is fetal blood, and repeated washings were conducted by use of saline. Each specimen was transferred to a Minisorb tube.
During days 3-5 after delivery, while the mother was still at the hospital, transitional milk was collected directly into acid-rinsed 250 ml polyethylene bottles (Kartell, Einasco, Milano, Italy). Collection of a minimum of 50 mL from each mother was attempted. All liquid and tissue samples were immediately frozen at -20°.
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For mercury measurements, hair samples of at least 100 mg (usually of 5-8 cm length) were cut with scissors close to the root from the occipital area; the hair sample was tied with a cotton thread and saved in a small, marked envelope. For analyses of organochlorine compounds, 2 g of serum and milk were used. To compensate for lower lipid contents, about 5 g of placenta and cord tissue were applied for these analyses. Analytical measurements of the 58 target analytes were performed by gas chromatography isotope dilution high resolution mass spectrometry (GC-IDHRMS) employing a MAT95XP (ThermoFinnigan MAT, Bremen, Germany) instrument (3). All organohalogen laboratory results were reviewed and approved by a quality assurance officer to assure that they conform to acceptable quality standards. However, the tissue samples analyzed were not analyzed with quality assurance/quality control (QA/QC) samples because there are no QC samples available for cord and placenta. The tissues were, however, measured by isotope-dilution high resolution mass spectrometry, which is the most accurate and precise method of quantification for such chemicals. The isotope-dilution method includes the spiking of the tissue with isotopically labeled internal standards that are chemically identical to the analytes being measured. Since the matrix analytes and isotopically labeled analytes are chemically identical, the ratio of the analytes is identical throughout the extraction and cleanup steps. This ratio is used to calculate the quantitative amount of analytes present in the tissues. The mass transitions, collision energies, and tube lens settings were optimized individually for all the compounds. The compounds were quantitated by use of the 13C-isotope-labeled analogues as internal standards (except for PFHxS, which was calculated by use of the internal standard for PFOA). The extraction of the serum samples was performed by manual solid-phase extraction, and an aliquot of 30 µL was injected into the LC-MS/MS system. The limit of detection was < 0.05 ng/mL for PFHxS, PFOA, PFNA, and PFDeA, and it was < 0.1 ng/mL for PFOS.
PCBs
The analyses of the milk specimens were conducted at CDC, through use of a modification of the method used for measuring PFCS in serum (7) . Briefly, 275 µL of 0.1 M formic acid and 25 µL of internal standard solution were added to 100 µL of milk. The spiked milk was vortex-mixed and sonicated, then injected into a Symbiosis on-line SPE-HPLC system (Spark Holland, Plainsboro, NJ), allowing for the preconcentration of the
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target PFCs on a Polaris C18 cartridge (7 mm, 10 × 1 mm; Spark Holland). This column was automatically positioned in front of a Betasil C8 HPLC column (3 x 50 mm, 5 µm;
ThermoHypersil-Keystone, Bellefonte, PA) for the chromatographic separation of the PFCs (20mM ammonium acetate (pH 4) in water (mobile phase A) and methanol (mobile phase B)). Detection and quantification used negative-ion TurboIonspray ionization-tandem mass spectrometry on an API 4000 mass spectrometer (Applied Biosystems, Foster City, CA).
The limits of detection ranged between 0.1 and 0.2 ng/mL, depending on the analyte. In addition to the calibration standards, blanks and quality control (QC) materials were analyzed along with the samples to ensure the accuracy and reliability of the data across time. Results for quality control materials were evaluated by use of standard statistical probability rules (8) .
Trace elements. All samples were measured at the University of Southern Denmark by atomic absorption; tissue samples were freeze-dried before analysis. For lead, cadmium, and selenium, we used a Perkin-Elmer model 5100 atomic absorption spectrometer with
Zeeman background correction, HGA-600 graphite furnace, and an AS-60 autosampler (Perkin-Elmer, Norwalk, CT, USA). All samples were analyzed in duplicate. Average detection limits were 0.03 µg/L for cadmium and 1.7 µg/L for lead; for approximately 0.1 g of dried tissue dissolved in 500 µL of dilute acid, these limits correspond to about 0.15 ng/g and 8.5 ng/g for tissue concentrations of cadmium and lead, respectively. Mercury was determined by duplicate analyses using flow-injection cold-vapor atomic absorption spectrometry after digestion of the sample in a microwave oven (9). 
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